Key statistics
On Friday, Longboard Pharmaceuticals Inc (LBPH:NMQ) closed at 59.21, -0.44% below its 52-week high of 59.47, set on Oct 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 59.28 |
---|---|
High | 59.35 |
Low | 59.19 |
Bid | 59.11 |
Offer | 59.48 |
Previous close | 59.17 |
Average volume | 6.26m |
---|---|
Shares outstanding | 39.03m |
Free float | 33.97m |
P/E (TTM) | -- |
Market cap | 2.31bn USD |
EPS (TTM) | -2.16 USD |
Data delayed at least 15 minutes, as of Oct 18 2024 21:00 BST.
More ▼
Press releases
- Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline
- Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome
- Longboard Pharmaceuticals Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Bexicaserin (LP352) in Dravet Syndrome
- Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
- Longboard Pharmaceuticals to Participate in Four Upcoming Investor Conferences in September
- Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress
- Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on September 16, 2024
- Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1
More ▼